Teleflex (NYSE:TFX) Announces Earnings Results, Beats Expectations By $0.03 EPS

Teleflex (NYSE:TFX) posted its earnings results on Thursday. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03, Zacks reports. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Trading Down 20.7 %

Shares of Teleflex stock traded down $36.76 on Thursday, hitting $140.87. 1,929,834 shares of the company’s stock traded hands, compared to its average volume of 573,671. Teleflex has a one year low of $135.95 and a one year high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.54 billion, a PE ratio of 27.98, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. The firm’s 50-day moving average price is $177.07 and its two-hundred day moving average price is $206.17.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TFX. Mizuho lowered their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Truist Financial lowered their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.